The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction.
about
Applications of CYP450 testing in the clinical settingA Model Based Cost-Effectiveness Analysis of Routine Genotyping for CYP2D6 among Older, Depressed Inpatients Starting Nortriptyline PharmacotherapyPharmacogenetic testing revisited: 5' nuclease real-time polymerase chain reaction test panels for genotyping CYP2D6 and CYP2C19.Geneva cocktail for cytochrome p450 and P-glycoprotein activity assessment using dried blood spots.Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safetyAltered CYP2C9 activity following modulation of CYP3A4 levels in human hepatocytes: an example of protein-protein interactions.Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort studyCopy number variants in pharmacogenetic genes.Molecular mechanisms of the microsomal mixed function oxidases and biological and pathological implicationsClinical epidemiology and pharmacology of CYP2D6 inhibition related to breast cancer outcomes.Distribution of the most Common Genetic Variants Associated with a Variable Drug Response in the Population of the Republic of Macedonia.Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatmentLimited predictive value of achieving beneficial plasma (Z)-endoxifen threshold level by CYP2D6 genotyping in tamoxifen-treated Polish women with breast cancer.Exploring the role of drug-metabolising enzymes in antidepressant side effects.Clinical and biomarker predictors of side effects from tamoxifenGenetic polymorphisms analysis of CYP2D6 in the Uygur population.Human pain and genetics: some basicsTafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial.Influence of CYP2D6 polymorphisms on serum levels of tamoxifen metabolites in Spanish women with breast cancer(13)C breath tests in personalized medicine: fiction or reality?Impact of gene expression profiling in lymphoma diagnosis and prognosis.Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations.CYP2C19*2 polymorphism is associated with increased survival in breast cancer patients using tamoxifen.CYP450 genotype and aggressive behavior on selective serotonin reuptake inhibitors.Flexible and Scalable Full-Length CYP2D6 Long Amplicon PacBio Sequencing.Evaluating the impact of missenses mutations in CYP2D6*7 and CYP2D6*14A: does it compromise tamoxifen metabolism?CYP2D6 Genetic Polymorphisms and Phenotypes in Different Ethnicities of Malaysian Breast Cancer Patients.Genetic epidemiology of pharmacogenetic variants in South East Asian Malays using whole-genome sequences.CYP2D6 allele distribution in Macedonians, Albanians and Romanies in the Republic of Macedonia.Single Nucleotide Polymorphisms and the Central Nervous System: Potential Biomarkers in Identifying Suicide RiskPharmacokinetic profile of dextromethorphan hydrobromide in a syrup formulation in children and adolescents.Prediction of drug response and safety in clinical practice.Influence of CYP2D6-genotype on tamoxifen efficacy in advanced breast cancer.Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection.Genetic differences in cytochrome P450 enzymes and antidepressant treatment response.Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study).Evaluation of Mutual Drug-Drug Interaction within Geneva Cocktail for Cytochrome P450 Phenotyping using Innovative Dried Blood Sampling Method.Practical recommendations for pharmacogenomics-based prescription: 2010 ESF-UB Conference on Pharmacogenetics and Pharmacogenomics.Impact of CYP2D6 Functional Allelic Variations on Phenoconversion and Drug-Drug Interactions.Donepezil plasma concentrations, CYP2D6 and CYP3A4 phenotypes, and cognitive outcome in Alzheimer's disease.
P2860
Q24621760-07E0DFA1-34E2-4BC4-A534-B41111189799Q28468503-9E2C1526-D6E1-42D0-B45B-25B580C6583CQ33597438-5858619A-AD78-45AB-AD77-058DD8604DA9Q34116690-1AF262D6-6A47-43EB-9E39-879F408174EFQ34123368-4916E34D-865F-477C-901A-9BEF2B3DC77FQ34360051-3C0D92A1-7601-47EC-A5D6-7A1924E7E93FQ34565428-7D36C2C0-9B37-4DD0-9418-1AA81D1D3241Q34975631-822AE295-9817-4D48-B6F9-D33418F38144Q35024501-CE65052A-5E83-41B0-9946-A161ABC1930FQ35058455-41E350FC-75CF-4E51-B0E0-0F7FA013BBA7Q35549639-50928309-F161-4E48-9F4A-3329610D7D40Q35617340-CFA04199-B7D8-4EC7-89DC-E9DB84833FB8Q35732619-F2B35DF0-FA0C-466B-B928-1012BE7335B4Q35780023-331E6A84-3093-4403-8380-05896B8F7B87Q35911174-F42F5634-9FCC-45D2-8DC1-BD07EB0F2471Q36031075-A40730FE-5655-4A51-99A4-9C5C3BADB4DAQ36110585-A739489E-E66A-445F-BBCF-933864258D1AQ36591835-B835A5B7-8504-42C6-ADB6-DA5F148D6282Q36909858-DBFC03BC-D733-470C-8838-AA612CD3850CQ37628680-D4223DC0-9D96-4620-9BC4-3E8688901328Q37831960-9EDA162E-1FDE-4B4F-BEA3-C51EC4E5E7D1Q38260323-C3A7CFC5-0852-4E4B-A75B-0EE49D723271Q38442184-F08B0FD1-0E68-4B12-8CCF-56F5662DB517Q38805909-2E66D9EC-2AE5-4D0D-B247-B995B2AE7622Q39043568-87F2916D-7555-42BA-ACBF-FF8CDB659E1CQ39864884-8FADB6EB-D524-43E0-92F7-2E9F57FC9DB2Q40382805-7C425015-EA30-4B09-B150-E3F4D39A29A4Q40728342-F69D6154-21EB-4FA2-9F04-C58EF8170F44Q41110398-7D064830-1236-4086-8355-EEFB74032EEFQ42360913-45D66A0B-0552-4308-8BFC-DA4E4B606C57Q42672227-B6518ADC-2AB5-4E51-96A5-600A503662C6Q42870458-CB87DB63-791A-4309-814D-8C9B26CFE18CQ43987491-4BDA5BFD-99FB-4F21-A7A6-7EC218AC4D5EQ45356395-E842F832-DC58-4346-8A0C-E4E95D6C02D6Q45729383-C0F152E9-14E2-497A-9CDF-C784335F2050Q46850739-8BCF7ED9-B0B3-4495-968F-51285F7705AAQ47449167-D47FD4B3-B73F-4DE7-902C-9CAB895AE907Q47597667-9EB86338-0729-4D8F-A33B-BFDE4C53C12FQ47937029-84E781F0-92AB-4B9C-BD96-5B3812D6CDF8Q50539194-E5F871AF-92E4-4F73-A482-E3CBFAAD68C6
P2860
The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
The AmpliChip CYP450 test: cyt ...... ment and phenotype prediction.
@en
The AmpliChip CYP450 test: cyt ...... ment and phenotype prediction.
@nl
type
label
The AmpliChip CYP450 test: cyt ...... ment and phenotype prediction.
@en
The AmpliChip CYP450 test: cyt ...... ment and phenotype prediction.
@nl
prefLabel
The AmpliChip CYP450 test: cyt ...... ment and phenotype prediction.
@en
The AmpliChip CYP450 test: cyt ...... ment and phenotype prediction.
@nl
P2093
P2860
P356
P1476
The AmpliChip CYP450 test: cyt ...... ment and phenotype prediction.
@en
P2093
D Hochstrasser
J Desmeules
M C Rebsamen
M F Rossier
P2860
P2888
P356
10.1038/TPJ.2008.7
P577
2008-07-01T00:00:00Z